Results 41 to 50 of about 201,919 (214)

Precision medicine to identify, prevent, and treat pediatric obesity [PDF]

open access: yes
Pediatric obesity is a growing health concern that has many secondary adverse health implications. Personalized medicine is a tool that can be used to optimize diagnosis and treatments of many diseases.
Tillman, Emma M., Mertami, Selsbiel
core   +1 more source

Tirzepatide, a dual GIP/GLP1-receptor co-agonist preserves cardiac function and improves survival in angiotensin II-induced heart failure model in mice: comparison to liraglutide

open access: yesCardiovascular Diabetology
Background Incretin analogues, used for the treatment of type 2 diabetes mellitus and obesity, such as GLP1-receptor agonist liraglutide (Lira) have been shown to reduce major adverse cardiac events in recent clinical trials of heart failure. Tirzepatide
Zsombor I. Hegedűs   +9 more
doaj   +1 more source

Information needs of physicians regarding the diagnosis of rare diseases: a questionnaire-based study in Belgium

open access: yesOrphanet Journal of Rare Diseases, 2019
Background Late and misdiagnoses of rare disease patients are common and often result in medical, physical and mental burden for the patient, and financial and emotional burden for the patient’s family.
Liese Vandeborne   +4 more
doaj   +1 more source

Pharmacotherapy of Essential Tremor

open access: yes, 2013
Essential tremor (ET) is a common movement disorder but its pathogenesis remains poorly understood. This has limited the development of effective pharmacotherapy.
František Cibulcík   +2 more
core   +1 more source

Implementing the flipped classroom model to enhance knowledge retention in pharmacology: a local case study at Semmelweis university

open access: yesBMC Medical Education
Background The flipped classroom (FC) approach has demonstrated efficacy in enhancing the learning process, including within higher education contexts such as medical education.
Zsófia Onódi   +4 more
doaj   +1 more source

Risk Assessment of Drug‐Induced Long QT Syndrome for Some COVID‐19 Repurposed Drugs

open access: yesClinical and Translational Science, 2021
The risk‐benefit ratio associated with the use of repurposed drugs to treat severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2)‐related infectious coronavirus disease 2019 (COVID‐19) is complicated because benefits are awaited, not proven.
Veronique Michaud   +6 more
doaj   +1 more source

Applicability of drug-related problem (DRP) classification system for classifying severe medication errors

open access: yesBMC Health Services Research, 2023
Background Several classification systems for medication errors (MEs) have been established over time, but none of them apply optimally for classifying severe MEs.
Carita Linden-Lahti   +3 more
doaj   +1 more source

Update on the pharmacotherapy of obesity.

open access: yes, 1998
Click on the Resource Link to access the article (may not be free).Objective: To review recent developments in the pharmacotherapy of obesity, including the agents currently approved for use in the management of obesity and those under development. Data
Lomaestro, B M, Malone, M, Cerulli, J
core   +1 more source

Effect of Increasing or Decreasing Use of Polypharmacy on Recovery of Activities of Daily Living in Patients With Stroke in the Recovery-Phase Rehabilitation Ward: A Retrospective Cohort Study Using Propensity Score Matching

open access: yesStroke Research and Treatment
Conclusion: In patients with stroke, reducing rather than increasing the number of drugs administered during recovery-phase rehabilitation could improve rehabilitation outcomes.
Shunsuke Hanaoka   +4 more
doaj   +1 more source

Flurbiprofen ameliorated obesity by attenuating leptin resistance induced by endoplasmic reticulum stress

open access: yesEMBO Molecular Medicine, 2014
Endoplasmic reticulum (ER) stress, caused by the accumulation of unfolded proteins, is involved in the development of obesity. We demonstrated that flurbiprofen, a nonsteroidal anti‐inflammatory drug (NSAID), exhibited chaperone activity, which reduced ...
Toru Hosoi   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy